Procrastination isn’t laziness. It is overwhelm, avoidance, and the human brain trying to dodge discomfort. With tiny steps, ...

Here are seven biopharma-related trends for 2026 that have emerged from GEN interviews with experts and other industry stakeholders, and from reviews of reports and public statements.

The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer ...

AI can help design AI systems: automating architecture choices, discovering algorithms, and optimizing hardware ...

Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...

For many, the festive season conjures images of cosy gatherings, twinkling lights and joyful celebration. But beneath the ...

Innovation fails when every pilot starts from scratch; the chassis approach shows how to move fast with vendors while keeping ...

RXRX Stock jumps after JPMorgan upgrade and trial data boost, fueling investor optimism in Recursion’s AI drug discovery ...

Vision Marine Technologies Announces Pricing of Public Offering of 32M Units; Expects Gross Proceeds of $9.6M; Offering Expected to Close Dec. 19; Plans to Use Proceeds for General Corporate Purposes, ...

Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” o7, 2025. This upgrade comes as the stock trades ...

Patronus AI unveiled “Generative Simulators,” adaptive “practice worlds” that replace static benchmarks with dynamic ...

There are plenty different productivity methods out there, but the right one for you depends on your needs. Here are seven of ...